A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration

Caterina Ierano, Paola Giuliano, Crescenzo D'Alterio, Michele Cioffi, Valentina Mettivier, Luigi Portella, Maria Napolitano, Antonio Barbieri, Claudio Arra, Giuseppina Liguori, Renato Franco, Giuseppe Palmieri, Carla Rozzo, Roberto Pacelli, Giuseppe Castello, Stefania Scala

Research output: Contribution to journalArticle

Abstract

The chemokine receptor CXCR4 is widely expressed in human cancers and regulates cell invasion, proliferation and survival. Because mutations in the CXCR4 gene could regulate its function we sequenced the coding region of the CXCR4 gene in 18 human melanoma and 3 human colon carcinoma cell lines. The same somatic point mutation (G574A; V160I) in the fourth transmembrane region of CXCR4 was detected in one colon cancer cell line (PD) and one melanoma cell line (LB). CXCR4 was expressed and functional in both PD and LB cells, PD and LB cells migrated specifically toward the receptor ligand, CXCL12 and P-Erk was specifically induced by CXCL12. To give insight into the function of the mutant CXCR4 receptor, human A431, epidermoid carcinoma cells, were stably transfected with both mutant and wild type CXCR4. In vitro, A431 cells harboring CXCR4 G574A migrated specifically toward CXCL12 and CXCL12 induced ERK phosphorylation. Interestingly, in vivo studies showed that the growth of A431 tumors harboring CXCR4G574A was delayed compared to those harboring WT CXCR4. As expected, treatment with AMD3100, a specific CXCR4 inhibitor, reduced the in vivo growth of CXCR4G574A tumor bG574A but surprisingly, increased the growth of CXCR4G574A A431 cells. This is the first report of a spontaneously occurring, functionally active CXCR4 mutation in human cancer cells. While the mutation impairs cell growth in vivo, the CXCR4 inhibitor, AMD3100, stimulated the growth of cells harboring CXCR4G574A.

Original languageEnglish
Pages (from-to)1228-1237
Number of pages10
JournalCell Cycle
Volume8
Issue number8
Publication statusPublished - Apr 15 2009

Fingerprint

Chemokine Receptors
Point Mutation
Cell Movement
Neoplasms
Growth
Cell Line
Mutation
Melanoma
CXCR4 Receptors
Colonic Neoplasms
Genes
Squamous Cell Carcinoma
Cell Survival
Colon
Phosphorylation
Cell Proliferation
Ligands
Carcinoma

Keywords

  • AMD3100
  • Chemokine receptor
  • Chemotactic factor
  • Chemotaxis
  • Colon cancer
  • CXC chemokine receptor
  • CXCL12
  • CXCR4
  • ERK
  • G-protein coupled receptor (GPCR)
  • Gi subfamily
  • Melanoma
  • pERK

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Developmental Biology

Cite this

Ierano, C., Giuliano, P., D'Alterio, C., Cioffi, M., Mettivier, V., Portella, L., ... Scala, S. (2009). A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration. Cell Cycle, 8(8), 1228-1237.

A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration. / Ierano, Caterina; Giuliano, Paola; D'Alterio, Crescenzo; Cioffi, Michele; Mettivier, Valentina; Portella, Luigi; Napolitano, Maria; Barbieri, Antonio; Arra, Claudio; Liguori, Giuseppina; Franco, Renato; Palmieri, Giuseppe; Rozzo, Carla; Pacelli, Roberto; Castello, Giuseppe; Scala, Stefania.

In: Cell Cycle, Vol. 8, No. 8, 15.04.2009, p. 1228-1237.

Research output: Contribution to journalArticle

Ierano, C, Giuliano, P, D'Alterio, C, Cioffi, M, Mettivier, V, Portella, L, Napolitano, M, Barbieri, A, Arra, C, Liguori, G, Franco, R, Palmieri, G, Rozzo, C, Pacelli, R, Castello, G & Scala, S 2009, 'A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration', Cell Cycle, vol. 8, no. 8, pp. 1228-1237.
Ierano C, Giuliano P, D'Alterio C, Cioffi M, Mettivier V, Portella L et al. A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration. Cell Cycle. 2009 Apr 15;8(8):1228-1237.
Ierano, Caterina ; Giuliano, Paola ; D'Alterio, Crescenzo ; Cioffi, Michele ; Mettivier, Valentina ; Portella, Luigi ; Napolitano, Maria ; Barbieri, Antonio ; Arra, Claudio ; Liguori, Giuseppina ; Franco, Renato ; Palmieri, Giuseppe ; Rozzo, Carla ; Pacelli, Roberto ; Castello, Giuseppe ; Scala, Stefania. / A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration. In: Cell Cycle. 2009 ; Vol. 8, No. 8. pp. 1228-1237.
@article{b4ecfa54cffc432b9b8df6ebcdfed6c8,
title = "A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration",
abstract = "The chemokine receptor CXCR4 is widely expressed in human cancers and regulates cell invasion, proliferation and survival. Because mutations in the CXCR4 gene could regulate its function we sequenced the coding region of the CXCR4 gene in 18 human melanoma and 3 human colon carcinoma cell lines. The same somatic point mutation (G574A; V160I) in the fourth transmembrane region of CXCR4 was detected in one colon cancer cell line (PD) and one melanoma cell line (LB). CXCR4 was expressed and functional in both PD and LB cells, PD and LB cells migrated specifically toward the receptor ligand, CXCL12 and P-Erk was specifically induced by CXCL12. To give insight into the function of the mutant CXCR4 receptor, human A431, epidermoid carcinoma cells, were stably transfected with both mutant and wild type CXCR4. In vitro, A431 cells harboring CXCR4 G574A migrated specifically toward CXCL12 and CXCL12 induced ERK phosphorylation. Interestingly, in vivo studies showed that the growth of A431 tumors harboring CXCR4G574A was delayed compared to those harboring WT CXCR4. As expected, treatment with AMD3100, a specific CXCR4 inhibitor, reduced the in vivo growth of CXCR4G574A tumor bG574A but surprisingly, increased the growth of CXCR4G574A A431 cells. This is the first report of a spontaneously occurring, functionally active CXCR4 mutation in human cancer cells. While the mutation impairs cell growth in vivo, the CXCR4 inhibitor, AMD3100, stimulated the growth of cells harboring CXCR4G574A.",
keywords = "AMD3100, Chemokine receptor, Chemotactic factor, Chemotaxis, Colon cancer, CXC chemokine receptor, CXCL12, CXCR4, ERK, G-protein coupled receptor (GPCR), Gi subfamily, Melanoma, pERK",
author = "Caterina Ierano and Paola Giuliano and Crescenzo D'Alterio and Michele Cioffi and Valentina Mettivier and Luigi Portella and Maria Napolitano and Antonio Barbieri and Claudio Arra and Giuseppina Liguori and Renato Franco and Giuseppe Palmieri and Carla Rozzo and Roberto Pacelli and Giuseppe Castello and Stefania Scala",
year = "2009",
month = "4",
day = "15",
language = "English",
volume = "8",
pages = "1228--1237",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "8",

}

TY - JOUR

T1 - A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration

AU - Ierano, Caterina

AU - Giuliano, Paola

AU - D'Alterio, Crescenzo

AU - Cioffi, Michele

AU - Mettivier, Valentina

AU - Portella, Luigi

AU - Napolitano, Maria

AU - Barbieri, Antonio

AU - Arra, Claudio

AU - Liguori, Giuseppina

AU - Franco, Renato

AU - Palmieri, Giuseppe

AU - Rozzo, Carla

AU - Pacelli, Roberto

AU - Castello, Giuseppe

AU - Scala, Stefania

PY - 2009/4/15

Y1 - 2009/4/15

N2 - The chemokine receptor CXCR4 is widely expressed in human cancers and regulates cell invasion, proliferation and survival. Because mutations in the CXCR4 gene could regulate its function we sequenced the coding region of the CXCR4 gene in 18 human melanoma and 3 human colon carcinoma cell lines. The same somatic point mutation (G574A; V160I) in the fourth transmembrane region of CXCR4 was detected in one colon cancer cell line (PD) and one melanoma cell line (LB). CXCR4 was expressed and functional in both PD and LB cells, PD and LB cells migrated specifically toward the receptor ligand, CXCL12 and P-Erk was specifically induced by CXCL12. To give insight into the function of the mutant CXCR4 receptor, human A431, epidermoid carcinoma cells, were stably transfected with both mutant and wild type CXCR4. In vitro, A431 cells harboring CXCR4 G574A migrated specifically toward CXCL12 and CXCL12 induced ERK phosphorylation. Interestingly, in vivo studies showed that the growth of A431 tumors harboring CXCR4G574A was delayed compared to those harboring WT CXCR4. As expected, treatment with AMD3100, a specific CXCR4 inhibitor, reduced the in vivo growth of CXCR4G574A tumor bG574A but surprisingly, increased the growth of CXCR4G574A A431 cells. This is the first report of a spontaneously occurring, functionally active CXCR4 mutation in human cancer cells. While the mutation impairs cell growth in vivo, the CXCR4 inhibitor, AMD3100, stimulated the growth of cells harboring CXCR4G574A.

AB - The chemokine receptor CXCR4 is widely expressed in human cancers and regulates cell invasion, proliferation and survival. Because mutations in the CXCR4 gene could regulate its function we sequenced the coding region of the CXCR4 gene in 18 human melanoma and 3 human colon carcinoma cell lines. The same somatic point mutation (G574A; V160I) in the fourth transmembrane region of CXCR4 was detected in one colon cancer cell line (PD) and one melanoma cell line (LB). CXCR4 was expressed and functional in both PD and LB cells, PD and LB cells migrated specifically toward the receptor ligand, CXCL12 and P-Erk was specifically induced by CXCL12. To give insight into the function of the mutant CXCR4 receptor, human A431, epidermoid carcinoma cells, were stably transfected with both mutant and wild type CXCR4. In vitro, A431 cells harboring CXCR4 G574A migrated specifically toward CXCL12 and CXCL12 induced ERK phosphorylation. Interestingly, in vivo studies showed that the growth of A431 tumors harboring CXCR4G574A was delayed compared to those harboring WT CXCR4. As expected, treatment with AMD3100, a specific CXCR4 inhibitor, reduced the in vivo growth of CXCR4G574A tumor bG574A but surprisingly, increased the growth of CXCR4G574A A431 cells. This is the first report of a spontaneously occurring, functionally active CXCR4 mutation in human cancer cells. While the mutation impairs cell growth in vivo, the CXCR4 inhibitor, AMD3100, stimulated the growth of cells harboring CXCR4G574A.

KW - AMD3100

KW - Chemokine receptor

KW - Chemotactic factor

KW - Chemotaxis

KW - Colon cancer

KW - CXC chemokine receptor

KW - CXCL12

KW - CXCR4

KW - ERK

KW - G-protein coupled receptor (GPCR)

KW - Gi subfamily

KW - Melanoma

KW - pERK

UR - http://www.scopus.com/inward/record.url?scp=65949095206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65949095206&partnerID=8YFLogxK

M3 - Article

C2 - 19305148

AN - SCOPUS:65949095206

VL - 8

SP - 1228

EP - 1237

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 8

ER -